Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients
Clinical trial NCT05618496 · COMPLETED
Trial details
- NCT number
- NCT05618496
- Sponsor
- Contipro Pharma a.s.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2023-10-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.